{"code":"0","data":{"overDate":"2025-12-01","note":null,"addTime":null,"proofOrSerialCode":"2018-441900-75-03-001075","submitDate":"2018/01/25 11:24:23","fullName":"东莞市发展和改革局","updateTime":"2022/09/27 09:16:46","expiryDate":"2020-01-26","applyOrgan":"广东三生制药有限公司","beginDate":"2019-04-01","hasStart":1,"sfjz":"0","scope":"该项目建成符合欧盟现行GMP标准的重组人促红素、二代重组人促红素、低分子肝素钙、单克隆抗体、mRNA疫苗等产品的生产线，规划设计生产厂房2幢，建筑面积约47000平方米，整体产能1亿支注射液/年，主要的原液、灌装及包装生产设备及公用工程配套设备采用进口设备供应商提供。","finishDate":"2018-01-25","id":"df3f1ea3-73ae-11ec-9ad9-fa164ee08b71","place":"东莞市松山湖园区信息路7号","stateFlagName":"办结（通过）","projectName":"广东三生制药有限公司东莞松山湖生物研发及产业化项目","totalInvest":93000.0000,"isValidity":"有效"},"message":"查询成功！","status":200}